ZIOPHARM Oncology Inc is a biotechnology company which acquires, develops, and commercializes cancer therapies that can address unmet medical needs through synthetic biology.

$3.31  -0.08 (-2.36%)
As of 04/09/2021 15:59:46 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/22/2005
Outstanding shares:  215,205,173
Average volume:  2,042,478
Market cap:   $714,481,174
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    98973P101
ISIN:        US98973P1012
Sedol:      B0HZZ46
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   5.62
PS ratio:   0.00
Return on equity:   -64.51%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy